SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-21-006627
Filing Date
2021-05-04
Accepted
2021-05-04 07:22:12
Documents
3
Period of Report
2021-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp150398_6k.htm 6-K 10108
2 EXHIBIT 99.1 dp150398_ex9901.htm EX-99.1 11747
3 GRAPHIC image_001.jpg GRAPHIC 4375
  Complete submission text file 0000950103-21-006627.txt   29043
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39071 | Film No.: 21885987
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences